EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiovascular Event Surveillance Following High-Dose Intravenous Mesenchymal Stem Cell Therapy: A Single-Center Real-World Observational Study

Takaaki Matsuoka, Nana Kobayashi

International Journal of Translational Medicine · 30.03.2026 · 6 (2) · 15

DOI: 10.3390/ijtm6020015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Translational Medicine, online erschienen am 30.03.2026. Verfasst von Takaaki Matsuoka und 1 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The long-term cardiovascular safety of high-dose intravenous mesenchymal stem cell (MSC) therapy remains insufficiently characterized in real-world clinical settings.

Methods

We conducted a single-center retrospective observational study of patients who received high-dose intravenous MSC therapy. Cardiovascular events were identified through follow-up records. Observed event incidence was compared descriptively with age-adjusted population reference data. Statistical analyses were performed using two-sided Poisson methods.

Results

Among treated patients, a total of four cardiovascular events were recorded during follow-up. The observed incidence did not demonstrate an excess signal compared with reference population data. No clustering of events was observed in the early post-infusion period. Sensitivity analyses yielded consistent findings.

Conclusions

In this real-world cohort, high-dose intravenous MSC therapy was not associated with an apparent increase in cardiovascular event incidence. Given the observational design and limited event number, larger prospective studies are warranted to further characterize long-term cardiovascular safety.

Zitieren

APA

Matsuoka, T., & Kobayashi, N. (2026). Cardiovascular Event Surveillance Following High-Dose Intravenous Mesenchymal Stem Cell Therapy: A Single-Center Real-World Observational Study. International Journal of Translational Medicine, 6(2), 15. https://doi.org/10.3390/ijtm6020015

Vancouver

Matsuoka T, Kobayashi N. Cardiovascular Event Surveillance Following High-Dose Intravenous Mesenchymal Stem Cell Therapy: A Single-Center Real-World Observational Study. International Journal of Translational Medicine. 2026;6(2):15. doi:10.3390/ijtm6020015

BibTeX
@article{Matsuoka2026,
  author = {Matsuoka, Takaaki and Kobayashi, Nana},
  title = {Cardiovascular Event Surveillance Following High-Dose Intravenous Mesenchymal Stem Cell Therapy: A Single-Center Real-World Observational Study},
  journal = {International Journal of Translational Medicine},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {15},
  doi = {10.3390/ijtm6020015}
}
Kostenlos starten →